Article citationsMore>>

Q. Ryan, et al., “FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2,” Oncologist, Vol. 13, No. 10, 2008, pp. 1114-1119.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top